echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The world's first!

    The world's first!

    • Last Update: 2022-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Compilenewborn

    Recently, GlaxoSmithKline (GSK) and Canadian biopharmaceutical company Medicago jointly announced that Health Canada has approved the new crown vaccine product Covifenz (plant-based virus-like particle [VLP], recombinant, adjuvant)


    Covifenz is the first plant-derived new crown vaccine, and this approval marks the world's first regulatory approval for Covifenz


    The Covifenz immunization schedule consisted of 2 intramuscular doses of the vaccine (3.


    In December 2021, GSK and Medicago announced the results of the Covifenz global Phase 3 placebo-controlled vaccine efficacy study


    The data showed that the overall vaccine efficacy of the Covifenz vaccine against all variants of SARS-COV-2 was 71% (95% CI: 58.


    Reference source: Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.